학술논문
TS01.02 Novel Anti–CTLA-4 Antibody Quavonlimab Plus Pembrolizumab as First-Line Therapy for NSCLC: Extended Follow-up From a Phase 1 Study
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology January 2021 16(1) Supplement:S48-S48
Subject
Language
ISSN
1556-0864